1. Home
  2. IPDN vs DCOY Comparison

IPDN vs DCOY Comparison

Compare IPDN & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Professional Diversity Network Inc.

IPDN

Professional Diversity Network Inc.

HOLD

Current Price

$0.60

Market Cap

759.0K

Sector

Technology

ML Signal

HOLD

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

HOLD

Current Price

$0.84

Market Cap

674.8K

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPDN
DCOY
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
759.0K
674.8K
IPO Year
2012
2014

Fundamental Metrics

Financial Performance
Metric
IPDN
DCOY
Price
$0.60
$0.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 104.1K
40.8K
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $22,054,219.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.42
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.10
$0.53
52 Week High
$7.70
$67.68

Technical Indicators

Market Signals
Indicator
IPDN
DCOY
Relative Strength Index (RSI) 25.19 28.56
Support Level $0.33 $0.53
Resistance Level $1.49 $1.24
Average True Range (ATR) 0.21 0.07
MACD -0.03 0.02
Stochastic Oscillator 4.89 0.00

Price Performance

Historical Comparison
IPDN
DCOY

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc provides access to networking, training, educational, and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates the majority of its revenue from the TalentAlly Network Segment.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: